Form 4 for TLSI TriSalus Life Sciences, Inc.
Accepted 2026-05-15 16:39:34 ET · period of report 2026-05-14 · accession 0001628280-26-035669 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-15 16:39 | 2026-05-14 | TLSI | HICKS KERRY R | Dir | A - Grant | $0.00 | +28.2K | 542.8K | +5% | $0 |
| D | 2026-05-15 16:39 | 2026-05-14 | TLSI | HICKS KERRY R | Dir | A - Grant | $0.00 | +56.4K | 145.6K | +63% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-14 | A | A | 28,201 | $0.00 | 542,790 | D | — | — | (F1) Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. |
| 2 | Derivative | Director Stock Option (right to buy) | 2026-05-14 | A | A | 56,403 | $0.00 | 145,625 | D | $2.52 · — to 2036-05-13 | 56,403 Common Stock | (F5) The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. |